Financial Perspectives’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.85K | Hold |
62
| – | – | ﹤0.01% | 579 |
|
|
2025
Q1 | $4.49K | Hold |
62
| – | – | ﹤0.01% | 577 |
|
|
2024
Q4 | $4.59K | Hold |
62
| – | – | ﹤0.01% | 575 |
|
|
2024
Q3 | $4.09K | Hold |
62
| – | – | ﹤0.01% | 538 |
|
|
2024
Q2 | $5.73K | Hold |
62
| – | – | ﹤0.01% | 504 |
|
|
2024
Q1 | $5.93K | Sell |
62
-67
| -52% | -$6.4K | ﹤0.01% | 497 |
|
|
2023
Q4 | $9.85K | Hold |
129
| – | – | ﹤0.01% | 470 |
|
|
2023
Q3 | $8.95K | Buy |
129
+62
| +93% | +$4.3K | ﹤0.01% | 459 |
|
|
2023
Q2 | $6.33K | Hold |
67
| – | – | ﹤0.01% | 490 |
|
|
2023
Q1 | $5.55K | Hold |
67
| – | – | ﹤0.01% | 501 |
|
|
2022
Q4 | $5.01K | Hold |
67
| – | – | ﹤0.01% | 511 |
|
|
2022
Q3 | $5.55K | Hold |
67
| – | – | ﹤0.01% | 496 |
|
|
2022
Q2 | $6.38K | Hold |
67
| – | – | ﹤0.01% | 488 |
|
|
2022
Q1 | $7.9K | Hold |
67
| – | – | ﹤0.01% | 489 |
|
|
2021
Q4 | $8.7K | Hold |
67
| – | – | ﹤0.01% | 457 |
|
|
2021
Q3 | $7.6K | Hold |
67
| – | – | ﹤0.01% | 469 |
|
|
2021
Q2 | $6.95K | Sell |
67
-5,548
| -99% | -$576K | ﹤0.01% | 499 |
|
|
2021
Q1 | $67K | Buy |
5,615
+5,548
| +8,281% | +$66.2K | ﹤0.01% | 537 |
|
|
2020
Q4 | $6.12K | Hold |
67
| – | – | ﹤0.01% | 455 |
|
|
2020
Q3 | $5.36K | Hold |
67
| – | – | ﹤0.01% | 414 |
|
|
2020
Q2 | $4.64K | Buy |
+67
| New | +$4.64K | ﹤0.01% | 414 |
|